AbbVie Inc. (BVMF:ABBV34)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of BRL 2.11 trillion. The enterprise value is 2.43 trillion.

Market Cap	2.11T
Enterprise Value	2.43T

Important Dates

The last earnings date was Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Jan 15, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	75.18%
Float	1.77B

Valuation Ratios

The trailing PE ratio is 91.32 and the forward PE ratio is 15.94.

PE Ratio	91.32
Forward PE	15.94
PS Ratio	6.25
PB Ratio	-118.43
P/TBV Ratio	n/a
P/FCF Ratio	21.46
P/OCF Ratio	20.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 24.76.

EV / Earnings	105.39
EV / Sales	7.74
EV / EBITDA	15.97
EV / EBIT	22.43
EV / FCF	24.76

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.41
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.84
Interest Coverage	7.30

Financial Efficiency

Return on equity (ROE) is 6,225.00% and return on invested capital (ROIC) is 22.49%.

Return on Equity (ROE)	6,225.00%
Return on Assets (ROA)	9.81%
Return on Invested Capital (ROIC)	22.49%
Return on Capital Employed (ROCE)	23.29%
Weighted Average Cost of Capital (WACC)	5.58%
Revenue Per Employee	5.91M
Profits Per Employee	404,500
Employee Count	57,000
Asset Turnover	0.45
Inventory Turnover	3.80

Taxes

In the past 12 months, AbbVie has paid 13.02 billion in taxes.

Income Tax	13.02B
Effective Tax Rate	35.83%

Stock Price Statistics

The stock price has increased by +0.07% in the last 52 weeks. The beta is 0.33, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+0.07%
50-Day Moving Average	74.22
200-Day Moving Average	71.55
Relative Strength Index (RSI)	52.13
Average Volume (20 Days)	2,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.57

Income Statement

In the last 12 months, AbbVie had revenue of BRL 336.87 billion and earned 23.06 billion in profits. Earnings per share was 13.00.

Revenue	336.87B
Gross Profit	241.27B
Operating Income	116.30B
Pretax Income	36.34B
Net Income	23.06B
EBITDA	161.13B
EBIT	116.30B
Earnings Per Share (EPS)	13.00

Balance Sheet

The company has 28.96 billion in cash and 376.75 billion in debt, with a net cash position of -347.79 billion.

Cash & Cash Equivalents	28.96B
Total Debt	376.75B
Net Cash	-347.79B
Net Cash Per Share	n/a
Equity (Book Value)	-17.78B
Book Value Per Share	-10.19
Working Capital	-78.36B

Cash Flow

In the last 12 months, operating cash flow was 104.82 billion and capital expenditures -6.69 billion, giving a free cash flow of 98.13 billion.

Operating Cash Flow	104.82B
Capital Expenditures	-6.69B
Free Cash Flow	98.13B
FCF Per Share	n/a

Margins

Gross margin is 71.62%, with operating and profit margins of 34.52% and 6.91%.

Gross Margin	71.62%
Operating Margin	34.52%
Pretax Margin	10.79%
Profit Margin	6.91%
EBITDA Margin	47.83%
EBIT Margin	34.52%
FCF Margin	29.13%

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 2.07%.

Dividend Per Share	1.53
Dividend Yield	2.07%
Dividend Growth (YoY)	4.13%
Years of Dividend Growth	6
Payout Ratio	11.75%
Buyback Yield	n/a
Shareholder Yield	2.07%
Earnings Yield	1.10%
FCF Yield	4.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 16.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	16

Scores

AbbVie has an Altman Z-Score of 2.26 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.26
Piotroski F-Score	8